星空体育官方入口网站网址大全-登录入口官网

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-05-23 ms4000001597486899 来自广东省

Received 2024-1-18
Major revision 2024-2-7
Received 2024-5-2
Minor revision 2024-5-2
Received 2024-5-2
Pre-acc 2024-5-22
等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭）

49 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-05-24 llllkn 来自浙江省

请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-07-02 Slove 来自江西省

纯生信文章还接收么

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-06-26 shademei 来自山西

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2023-10-30 秋思来自广东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：有和我一样，外审审了20天被拒了的吗5555……

45 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-04-22 ms1000001009157638 来自天津

审稿速度:2.0
偏重的研究方向：结直肠癌;临床
经验分享：2.27投稿
3.21大修
3.25修回
4.16pre-acc
4.20pre-fee
感谢期刊编辑

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-05-05 ms1000001009157638 来自天津

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：结直肠癌;临床
经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？

48 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-06-13 花卷卷来自河北省

请问这个期刊送审后拒稿的多不，还是多数会给修改的机会

59 0

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2024-05-02 科研小蔡姬来自广西

请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206141, encodeId=419b22061416f, content=Received 2024-1-18 Major revision 2024-2-7 Received 2024-5-2 Minor revision 2024-5-2 Received 2024-5-2 Pre-acc 2024-5-22 等着毕业的文章，中间出了意外，本来以为拿不了学位证了。主编大人真的人太好了，紧急处理了我的文章，孩子能毕业了，太感动了（哭） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b566160229, createdName=ms4000001597486899, createdTime=Thu May 23 09:51:21 CST 2024, time=2024-05-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206492, encodeId=c09b220649287, content=请问各位修回之后，还会再次送审然后旁边的replace消失吗？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLpoPPhtQvTy6ZNyQ95jvIy5Mg0FETNLcMqjrfaRfjvTAUCiaZmPHFBcHuhOZwcxMtUoINWicGI64Sw/132, createdBy=d64b5284505, createdName=llllkn, createdTime=Fri May 24 22:41:11 CST 2024, time=2024-05-24, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2212724, encodeId=5c4e2212e2407, content=纯生信文章还接收么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71545433422, createdName=Slove, createdTime=Tue Jul 02 10:10:19 CST 2024, time=2024-07-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211663, encodeId=ebce22116635e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：刚发了一篇，饮食结构和肿瘤发生关系，要求新颖性，改了好几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:35:09 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2165680, encodeId=a7d3216568091, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有和我一样，外审审了20天被拒了的吗5555……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43892032014, createdName=秋思, createdTime=Mon Oct 30 10:02:21 CST 2023, time=2023-10-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2199758, encodeId=fe672199e5898, content=审稿速度:2.0 偏重的研究方向：结直肠癌;临床 经验分享：2.27投稿 3.21大修 3.25修回 4.16pre-acc 4.20pre-fee 感谢期刊编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Mon Apr 22 10:40:52 CST 2024, time=2024-04-22, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2201816, encodeId=93d42201816b9, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：结直肠癌;临床 经验分享：昨天Proof了，需要多久才能在PubMed上见刊啊，我咋看到这个期刊最近发的都是3月的，4月没有文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Sun May 05 10:02:19 CST 2024, time=2024-05-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2209632, encodeId=ab6c22096327f, content=请问这个期刊送审后拒稿的多不，还是多数会给修改的机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210626/11584159ef9b48fb826a931627f16db0/8c4cc49a51c543e7bd5b0ce7cd20fa18.jpg, createdBy=0eea5533600, createdName=花卷卷, createdTime=Thu Jun 13 10:29:10 CST 2024, time=2024-06-13, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2201495, encodeId=6e3e22014955b, content=请问各位大佬，投稿之后状态就是会一直显示under review吗😂怎么知道他有没有送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c7be2502508, createdName=科研小蔡姬, createdTime=Thu May 02 19:44:37 CST 2024, time=2024-05-02, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154795, encodeId=6f5f2154e95be, content=8.21投稿，8.26送审，速度还可以吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e2a8122133, createdName=ms3000001935163602, createdTime=Sun Aug 27 15:14:51 CST 2023, time=2023-08-27, status=1, ipAttribution=广东省)]

2023-08-27 ms3000001935163602 来自广东省

8.21投稿，8.26送审，速度还可以吧。

100 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务